
Jonah Comstock
Editor-in-Chief at Pharmaphorum
Host at pharmaphorum Podcast
Health tech journalist. Editor in Chief, pharmaphorum. Tweets are my own. Profile photos by @SOSKI_photo & @SFBIZronleuty
Articles
-
1 week ago |
pharmaphorum.com | Jonah Comstock
April was a busy month for Boards, with a number of biotechs appointing new Chairs, as well as plenty of other Board seat changes. Read on for the highlights. Patient-turned-entrepreneur takes helm on Adcendo Board. Laura Shawyer has been named Chair of the Board of Directors at Adcendo ApS, a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) targeting cancers with high unmet medical needs.
-
1 week ago |
pharmaphorum.com | Jonah Comstock
Dan Gandor has spent his whole career pioneering digital techniques for pharma marketing and creating centres of excellence at pharma companies like Takeda and AbbVie. Last month, he joined pharmaphorum's parent company and pharma marketing agency EVERSANA as EVP and Head of Omnichannel and Digital Transformation. I caught up with Dan to find out why he made the leap from pharma to agency, why omnichannel marketing still matters, how he’s thinking about AI, and more.
-
1 week ago |
pharmaphorum.com | Jonah Comstock
Inizio Evoke strengthens creative leadership. Inizio Evoke, a UK-based global pharma commercialisation partner, has bolstered its creative team with two key appointments sharing the role of executive creative director. Tristen George previously served as SVP, group creative director, and partner at AbelsonTaylor Group, where she led client businesses and played a pivotal role in launching Nutrient, a new agency within the network.
-
1 week ago |
pharmaphorum.com | Jonah Comstock
We saw a range of hires in April in pharma-adjacent sectors like manufacturing and clinical research. Read on for the full update. New CEO for CRO. Oncodesign Services, a French CRO specialising in drug discovery and preclinical development, announced a new CEO: Dr Aidan Synnott. Synnott most recently served as corporate VP of global discovery services at Charles River Laboratories.
-
2 weeks ago |
pharmaphorum.com | Jonah Comstock
April saw quite a bit of movement in the biotech C-Suites, including both departures and arrivals. Read on for a whirlwind, worldwide tour of recent personnel moves. Leadership shuffle at Novo Nordisk. The departure of Camilla Sylvest, EVP commercial strategy and corporate affairs, from Novo Nordisk prompted some shuffling in the company’s executive management team.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 5K
- Tweets
- 2K
- DMs Open
- No

On the off-chance that this isn't muzzled, my social media coverage of #REpharmaUSA is happening elsewhere, where the skies are bluer....

The IRA prices are out and ... I guess the sky isn't falling? Savings for patients are significant, no one's going out of business, pharma's still not happy about the IRA. https://t.co/RyjXUUb5D1

My #BIO2024 live blog is now live! https://t.co/QRJsjc8iVk